Factory Mutual Insurance Co. increased its stake in Intuit Inc. by 27.7% in Q4, acquiring an additional 11,700 shares to own a total of 53,900 shares valued at $35.7 million. This move comes as Intuit faces competitive fears related to AI and analyst price target cuts, despite reporting strong earnings and raising FY2026 guidance. The stock is currently trading at multi-year/52-week lows, with a consensus "Moderate Buy" rating, but some analysts have recently lowered their price objectives.

Factory Mutual Insurance Co. reduced its stake in Wells Fargo & Company by 2.4% in the fourth quarter, selling 16,700 shares. Despite this, other institutional investors increased their holdings, and the company has received a "Moderate Buy" consensus rating from analysts with an average price target of $97.70. Wells Fargo recently announced a quarterly dividend of $0.45, bringing its annualized dividend to $1.80.

Factory Mutual Insurance Co. increased its stake in Arthur J. Gallagher & Co. by 30.3% in Q4, now holding 64,500 shares valued at $16.692 million. This comes as Arthur J. Gallagher & Co. beat quarterly EPS estimates, increased its dividend, and maintains a "Moderate Buy" consensus rating from analysts. However, some company VPs recently sold shares of the stock.

Factory Mutual Insurance Co. reduced its stake in American Tower Corporation (AMT) by 2.5% in the fourth quarter, selling 5,800 shares to hold 221,900 shares valued at $38.96 million. This comes as American Tower reported Q4 EPS of $1.75, missing analyst expectations, leading to several price target cuts despite a consensus "Moderate Buy" rating. The company also increased its quarterly dividend to $1.79, reflecting an annualized yield of approximately 4.0%.

Factory Mutual Insurance Co. increased its stake in Linde PLC by 10.3% in Q4 2025, bringing its total holdings to 97,700 shares valued at $41.66 million. Despite institutional growth and a raised price target from UBS, the company faces increased short interest and recent insider stock sales totaling over $9.7 million. Linde slightly surpassed Q4 earnings estimates and provided optimistic FY2026 guidance, while also increasing its quarterly dividend.

Cantor Fitzgerald Investment Advisors L.P. reduced its stake in Duke Energy Corporation by 11.7% in the fourth quarter, selling 14,203 shares, though still holding 106,935 shares valued at $12.53 million. The utilities provider exceeded Q4 earnings expectations with EPS of $1.50 and revenue of $7.94 billion. Despite recent insider selling by the CEO and an SVP, analysts generally rate DUK as a "Hold" with an average price target of $139.33.

Factory Mutual Insurance Co. reduced its stake in Union Pacific Corporation (NYSE:UNP) by 3.1% in the fourth quarter, selling 7,200 shares. Despite this, other institutional investors like Union Bancaire Privee UBP SA, Midwest Trust Co, CX Institutional, and Thrivent Financial for Lutherans increased their holdings in the railroad operator. The article also covers Union Pacific's recent stock performance, dividend announcement, and analyst ratings, noting an average "Moderate Buy" rating from brokerages.

Factory Mutual Insurance Co. significantly reduced its stake in CVS Health Corporation by 31.4% in Q4 2025, selling 141,100 shares and retaining 308,143 shares valued at approximately $24.45 million. Despite the institutional selling, CVS Health reported strong quarterly earnings, beating analyst estimates with $1.09 EPS on $105.69 billion in revenue, and declared a quarterly dividend of $0.665. The company's stock currently holds a "Moderate Buy" consensus rating from analysts, with an average target price of $94.95.

Cantor Fitzgerald Investment Advisors L.P. significantly increased its stake in International Flavors & Fragrances (IFF) by 38.1% in Q4, acquiring 54,971 additional shares. Concurrently, IFF Director Paul J. Fribourg bought 142,000 shares, boosting his personal holding. Despite missing quarterly EPS estimates, IFF recently paid a quarterly dividend of $0.40 per share, and analysts rate the stock as a "Moderate Buy."

Carnegie Investment Counsel significantly increased its stake in Northrop Grumman (NYSE:NOC) by 15.8% in the last quarter, bringing its total holdings to 55,010 shares valued at approximately $31.37 million. This move follows Northrop Grumman's strong Q4 earnings, which surpassed analyst estimates with EPS of $7.23 and revenue of $11.71 billion, and solid FY2026 guidance. Wall Street analysts maintain a "Moderate Buy" rating, with an average price target of $719.58, and institutional investors own a substantial 83.4% of the stock.